All data are based on the daily closing price as of December 5, 2024
l
LegoChem Biosciences
141080.KQ
74.49 USD
-0.78
-1.04%
Overview
Last close
74.49 usd
Market cap
2.71B usd
52 week high
100.30 usd
52 week low
24.64 usd
Target price
109.68 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
51.5708
Price/Book Value
6.0359
Enterprise Value
2.35B usd
EV/Revenue
32.8297
EV/EBITDA
2905.9731
Key financials
Revenue TTM
53.82M usd
Gross Profit TTM
12.60M usd
EBITDA TTM
-34.26M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
739.33B usd
Net debt
N/A usd
About
LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was formerly known as LegoChem Biosciences, Inc. and changed its name to LigaChem Biosciences Inc. in April 2024. LigaChem Biosciences Inc. was founded in 2006 and is headquartered in Daejeon, South Korea.